IPO registrations (S-1, F-1) · Registrants

NEXGEL, INC.

SEC CIK
1468929 · filings on EDGAR ↗
Former names
AquaMed Technologies, Inc. (2009–2019)
Registration
Form S-1, first filed 2019-01-09, last 2026-08-20; 4 initial registrations, 6 amendments
Outcome
Final prospectus filed 2021-12-27; declared effective 2021-05-07; withdrawal requested 2019-06-14
Industry (SIC)
Surgical & Medical Instruments & Apparatus 3841
Incorporated in
DE
Business address
2150 CABOT BLVD WEST,, SUITE B, Langhorne, PA 19047
EIN
26-4042544
Ticker
NXGL, NXGLW (Nasdaq, Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
NEXGEL, INC. on the corporate pages

Offering terms

Final price
$5.50 per share (424B4 filed 2021-12-27, an initial public offering)
Shares sold
2,585,000
Gross proceeds
$14,217,500 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol NXGL
Lead underwriters
Number of Units Maxim Group LLC (2,585,000 shares)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 16

FiledFormWhat it isName as filedEDGAR
2019-01-09S-1S-1 (registration)AquaMed Technologies, Inc.0001144204-19-001167 ↗
2019-03-12S-1/AS-1/A (amendment)AquaMed Technologies, Inc.0001144204-19-013366 ↗
2019-03-26S-1/AS-1/A (amendment)AquaMed Technologies, Inc.0001144204-19-015831 ↗
2019-04-19S-1/AS-1/A (amendment)AquaMed Technologies, Inc.0001144204-19-020424 ↗
2019-06-14RWRW (withdrawal request)AquaMed Technologies, Inc.0001144204-19-031041 ↗
2021-04-09S-1S-1 (registration)NEXGEL, INC.0001104659-21-048833 ↗
2021-05-07EFFECTEFFECT (declared effective)NEXGEL, INC.9999999995-21-001851 ↗
2021-11-09S-1S-1 (registration)NEXGEL, INC.0001104659-21-136084 ↗
2021-12-02S-1/AS-1/A (amendment)NEXGEL, INC.0001104659-21-145979 ↗
2021-12-06S-1/AS-1/A (amendment)NEXGEL, INC.0001104659-21-146733 ↗
2021-12-10S-1/AS-1/A (amendment)NEXGEL, INC.0001104659-21-148686 ↗
2021-12-21S-1MEFS-1MEF (added securities)NEXGEL, INC.0001104659-21-152316 ↗
2021-12-21EFFECTEFFECT (declared effective)NEXGEL, INC.9999999995-21-004776 ↗
2021-12-27424B4424B4 (final prospectus)NEXGEL, INC.0001104659-21-153274 ↗
2023-06-07EFFECTEFFECT (declared effective)NEXGEL, INC.9999999995-23-001655 ↗
2026-08-20S-1S-1 (registration)NEXGEL, INC.0001493152-26-039421 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2021-12-10S-1/Aregistration statement$1.002,065,935$2,065,935Nasdaq NXGL0primary document; price sentence, shares headline, proceeds computeddocument ↗
2021-12-27424B4final prospectus$5.502,585,000$14,217,500Nasdaq NXGL1primary document; price sentence, shares headline, proceeds table, underwriting table 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Adynxx, Inc.TenPercentOwner12019
Johnson David IanDirector,OfficerChief Executive Officer12019
Stein John NachumDirector; Director,TenPercentOwner132019–2025
BEZALEL PARTNERS LLCTenPercentOwner12019
STEFANSKY DAVIDDirector; Director,TenPercentOwner122019–2023
Levy Adam R.Director,Officer; Officer; Officer,TenPercentOwnerCEO; CEO and President; CEO & CFO; Chief Executive Officer252019–2026
ZELDIS JEROME BDirector92021–2025
glassman steven markDirector122021–2025
Drapczuk Adam E IIIOfficerChief Financial Officer52021–2024
Toledano Miranda JayneDirector32021–2023
Spinrad YaakovDirector22021–2022
Henry Scott RobertDirector222023–2026
MCGUIRE JOSEPH FOfficerChief Financial Officer12025
Ciardiello StevenDirector12025
Blackman Ian HowardOfficerChief Financial Officer12026
Harris Kevin McClainDirector12026
Kieser Brian JosephDirector22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2021-09-17NEXGEL, INC.Other Health Care$2,500,000$1,620,000201
2021-03-23NEXGEL, INC.Biotechnology$1,500,000$1,500,00011
2021-03-23NEXGEL, INC.Biotechnology$515,000$515,000121
2020-08-21NEXGEL, INC.Biotechnology$500,000$395,10051
2019-09-25AquaMed Technologies, Inc.Biotechnology$750,000$175,00021

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationNEXGEL, INC.FLState business registriesEIN (EXACT, as the state registration reports it)
Plan sponsorNEXGEL INCPAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerNEXGEL, INC.PAForm D private offeringsCIK (EXACT)
SEC filerNEXGEL, INC.SEC filers (EDGAR)CIK (EXACT)
Business registrationNexgel Inc.State business registriesname and state
Form 5500 plan sponsorNEXGEL INCEIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Surgical & Medical Instruments & Apparatus, PA first:

More with this interest.

In other datasets, the same topic (Technology) in PA:

Interests: Surgical & Medical Instruments & Apparatus · Technology